<DOC>
	<DOCNO>NCT01996436</DOCNO>
	<brief_summary>The primary objective study determine optimal intra-arterial drug treatment regimen arterial lumen restoration post cerebral vasospasm follow aneurysmal subarachnoid hemorrhage . The secondary objective evaluate clinical outcome 90 day post discharge follow optimal intra-arterial drug treatment cerebral vasospasm . We hypothesize Intra-arterial ( IA ) infusion combination multiple vasodilator efficacious single agent treatment cerebral vasospasm therapy . All procedure do part study standard hospital care procedures do treat cerebral vasospasm drug use FDA approve .</brief_summary>
	<brief_title>The Intra-arterial Vasospasm Trial</brief_title>
	<detailed_description>The primary objective study determine optimal intra-arterial drug treatment regimen arterial lumen restoration post cerebral vasospasm follow aneurysmal subarachnoid hemorrhage . The secondary objective evaluate clinical outcome 90 day post discharge follow optimal intra-arterial drug treatment cerebral vasospasm . This study prospective multicenter randomize trial . The primary outcome measure Post infusion improvement ratio ( PIIR ) assess 10 minute completion intra-arterial infusion . PIIR measure arterial lumen diameter pre post intra-arterial drug infusion present vasospasmic blood vessel . Modified Rankin score ( mRS ) 3 month post hospital discharge record secondary outcome assess clinical outcome . The intervention study part routine standard care ( SOC ) procedures cerebral vasospasm treatment . Following surgical endovascular intervention aneurysmal Subarachnoid Hemorrhage ( aSAH ) patient develop cerebral vasospasm refractory maximal medical management , endovascular treatment intra-arterial drug infusion single drug agent cocktail drug agent initiate . Study participant randomly assign one three treatment group one single drug agent cocktail drug agent intra-arterially administer . Pre &amp; post infusion vasospasmic vessel diameter compare . The change diameter quantify base mean percentage change . Three month post hospital discharge , study participant follow clinic evaluate clinical outcome . The study require 330 patient total . The patient population hospitalize patient present cerebral vasospasm post aneurysmal subarachnoid hemorrhage . Subjects stratify randomization 3 treatment group .</detailed_description>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Nicardipine</mesh_term>
	<criteria>Adult patient , age 1880 year old , rupture aneurysm ( ) experience cerebral vasospasm post operatively within 321 day . Inability obtain consent patient patient kin Pregnant woman less 18 year age 80 year age Hunt Hess Grade 5 SAH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cerebral vasospasm</keyword>
	<keyword>aneurysmal subarachnoid hemorrhage</keyword>
	<keyword>intra arterial drug treatment cerebral vasospasm</keyword>
	<keyword>nicardipine milrinone nitroglycerin verapamil</keyword>
</DOC>